← Alle mensen

YC

Yana Chapko

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

600- vs 400-mg Eerstelijns Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Gevorderd Breast Cancer: The AMALEE...
JAMA oncology · 1 november 2025
Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monothera...
European journal of cancer (Oxford, England : 1990) · 9 september 2025